CN106852726A - A kind of OPC microcapsules and preparation method thereof - Google Patents
A kind of OPC microcapsules and preparation method thereof Download PDFInfo
- Publication number
- CN106852726A CN106852726A CN201710035742.1A CN201710035742A CN106852726A CN 106852726 A CN106852726 A CN 106852726A CN 201710035742 A CN201710035742 A CN 201710035742A CN 106852726 A CN106852726 A CN 106852726A
- Authority
- CN
- China
- Prior art keywords
- opc
- microcapsules
- solution
- prepared
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Abstract
A kind of OPC microcapsules, by OPC, 1~30% lipophilic emulsifier that mass percent concentration is 0.1~5%, 1~10% shitosan, 1~10% glacial acetic acid, 1~30% water, 0.005~0.1% glutaraldehyde and the liquid fat of surplus are prepared from.The preparation method of above-mentioned microcapsules is additionally provided, by OPC, shitosan, glacial acetic acid heating for dissolving in water, water phase components is obtained;By lipophilic emulsifier, liquid fat Hybrid Heating and it is uniformly dispersed, oil phase component is obtained;Under stirring, water phase components are slowly added into oil phase component, uniform emulsion is obtained;Solidify during glutaraldehyde is added into emulsion, then sequentially pass through centrifugation, ethanol, petroleum ether, acetone dispersion air-dry to obtain OPC microcapsules.OPC microcapsules of the invention, can be such that OPC separates with external environment, effectively prevent strong destruction of the external environments such as periods of direct sunlight to OPC.
Description
Technical field
The invention belongs to field of fine chemical, be related to a kind of microcapsules, specifically a kind of OPC microcapsules and
Its preparation method.
Background technology
OPC belongs to condensed tannin, is that the one kind at the position such as core, skin or seed for being widely present in various plants is more
Phenolic compounds.
OPC is widely used in the fields such as food, medicine and cosmetics.
In field of medicaments, because OPC has active anticancer and the cardiovascular function of protection, and by as anti-cancer, preventing and treating
The active ingredient of cardiovascular disease medicine.
In field of food, OPC is used as a kind of natural preservative, the shelf life for extending food;It is external extensive
For in the health food such as lowering blood pressure and blood fat, antitumor, brain tonic;The dispensing or additive of ordinary food are also used for, to increase
The alimentary health-care function of food.
In cosmetic field, because OPC has anti-oxidant, Scavenging ability, also with elastase inhibitor activity
It is active with microcirculation is improved, so the skin care item containing OPC, can improve scytitis, prevent melanism, anti-aging.
However, the research to OPC stability shows, under high temperature easily there is thermal degradation, periods of direct sunlight pair in OPC
OPC has strong destruction.
Shitosan is the unique alkaline polysaccharide in natural polysaccharide, with unique physicochemical characteristics and biology work(
Energy.Shitosan and its catabolite are nontoxic, with biocompatibility, biodegradability, security and good moulding property etc.
Premium properties, and have certain anti-inflammation, promote the effect such as wound healing.Because shitosan has above superperformance and work
With, applied in the middle of cosmetics, both protect coated material, it is ensured that its structural intergrity and stability, can carry again
The utilization rate of coating high, makes it be absorbed to greatest extent.And the microcapsules prepared with shitosan have with obvious control
The release of effect thing and the effect of extension working substance curative effect.
In recent years, research of the various active materials in terms of dermatology and cosmeceutical is coated to be vigorously developed, it is poly- containing shell
The cosmetics of sugar have the unrivaled advantage of Traditional makeup, and it has good biocompatibility, security, slow release,
Cosmetics will be made to high-quality, high-grade development.
The content of the invention
For above-mentioned technical problem of the prior art, the invention provides a kind of OPC microcapsules and its preparation side
Method, described this OPC microcapsules and preparation method thereof will solve capsulated OPC of the prior art and exist
Easily there is thermal degradation under high temperature, the technical problem of strong destruction is vulnerable under periods of direct sunlight.
The invention provides a kind of OPC microcapsules, it is prepared from by the raw material of following mass percent:
Described lipophilic emulsifier is ceteareth -6, ceteareth -25, the poly- second two of cetyl
Alcohol/the dimethyl siloxane of polypropylene glycol -10/1, the polyricinoleate of polyglycereol -3, the isostearate of polyglycereol -2, polyglycereol -2
Double isostearates, the isostearate of polyglycereol -2 three, the pentaerythritol tetraisostearate of polyglycereol -2, sorbitan monooleate, dehydration
Sorbitan stearate, sorbitan sesquioleate, sorbitan trioleate, polyoxyethylene (2) oleyl alcohol ether, polyoxy
One or more mixtures for being constituted in ethene (10) oleyl alcohol ether;
Described liquid fat is caprylic capric glyceryl ester, isopropyl myristate, myristyl myristate, palm
Isopropyl propionate, isobutyl palmitate, ethylhexyl palmitate, isoamyl laurate, isostearic acid, isooctadecanol, pentaerythrite
Four isostearic acids, isostearic acid glyceryl ester, isopropyl isostearate, the pungent decylate of trimethylolpropane tris, neopentyl glycol two
In isostearic acid, cetearyl stearate, n-nonanoic acid cetearyl alcohol ester, PEG-7 cocounut oil acid glyceride, three isooctyl acid glyceride
One or more mixtures for being constituted.
Present invention also offers a kind of preparation method of above-mentioned OPC microcapsules, comprise the following steps:
1) OPC, lipophilic emulsifier, shitosan, glacial acetic acid, water, glutaraldehyde, liquid are weighed according to mass percent
State grease;
2) acetum is made by glacial acetic acid is soluble in water;
3) add chitosan into step 2) in prepared acetum, 30~60 DEG C are heated to being completely dissolved, quiet
Chitosan-acetic acid solution is obtained after putting removing bubble;
4) OPC is added to step 3) in prepared solution, 25~50 DEG C stir after it is first molten
Liquid;
5) lipophilic emulsifier is added in liquid fat, second is obtained after being stirred in 25~60 DEG C of waters bath with thermostatic control molten
Liquid;
6) in 25~60 DEG C of solution of heated at constant temperature second, second is stirred under the stir speed (S.S.) of 150rpm~1000rpm molten
Liquid, while the first solution is slowly dropped into in the second solution, emulsifies 0.5~4 hour;
7) in step 6) it is added dropwise in glutaraldehyde in the prepared system for completing, continue 150rpm~1000rpm's
Stirred 0.5~4 hour under stir speed (S.S.);
8) by step 7) prepared by reactant be fully transferred in centrifuge tube, under the rotating speed of 10000~40000rpm
Centrifugation, obtains sediment;
9) by step 8) in gained sediment use absolute ethyl alcohol and petroleum ether, washed product natural after being disperseed with acetone respectively
Volatilize, obtain OPC microcapsules.
The present invention is used as microcapsules by using lipophilic emulsifier, shitosan, glacial acetic acid, water, glutaraldehyde, liquid fat
Wall material, OPC is wrapped in the middle of wall material as core, first OPC, shitosan, glacial acetic acid heating for dissolving are existed
In water, water phase components are obtained;By lipophilic emulsifier, liquid fat Hybrid Heating and it is uniformly dispersed, oil phase component is obtained;Stirring
Under, water phase components are slowly added into oil phase component, uniform emulsion is obtained;Solidify during glutaraldehyde is added into emulsion,
Centrifugation is sequentially passed through again, and ethanol, petroleum ether, acetone dispersion air-dry to obtain OPC microcapsules.Meanwhile, wall material used, shell
The good biocompatibility of glycan, can promote absorption of the OPC on skin to permeate, and then improve the utilization of OPC
Efficiency, is conducive to it in the more wide application of ordinary food, health food, medicine, cosmetic field.
A kind of cladding OPC microcapsules of the invention, employ the shitosan with good biocompatibility as wall
Material coats OPC, and OPC microcapsules are prepared for by emulsion-crosslinking method using lipophilic emulsifier, liquid fat etc.,
Preparation process is simple, energy consumption are low, obtained microcapsules good sphericity, and size controlling is in nanometer range.
The present invention is compared with prior art, and its technological progress is significant.Prepared OPC microcapsules are for original
The problem that anthocyanidin is easily destroyed by external environments such as periods of direct sunlight, for the cladding of OPC provides suitable carrier, by original
Anthocyanidin separates with external environment, protects the structural intergrity and stability of OPC, and then improves OPC
Active utilization rate, promotion is developed with functionality is strong, the good penetrability cosmetics containing OPC active matter.
The present invention is mainly used in cosmetic technical field using OPC microcapsules prepared by emulsion-crosslinking method.
Brief description of the drawings
Fig. 1 is the microphotograph before OPC microcapsules centrifugation prepared by embodiment 1.
Specific embodiment
The invention will be further elaborated by the following examples, but is not intended to limit the present invention.
It is former containing 1% obtained by the OPC microcapsules of the gained of embodiments of the invention 1 and the comparative examples of embodiment 1
Anthocyanidin aqueous solution permeability data assay method is as follows:
1. instrument:The high performance liquid chromatographs of Agilent 1260, TP-6 intelligence penetrating absorption instrument.
2. operating procedure:
(1) reception liquid is configured:40% absolute ethyl alcohol of PBS cushioning liquid+60%.
(2) external osmotic deffusion experiment
1. weighed respectively with assay balance 10g or so containing 1% OPC microcapsules and containing the 1% OPC aqueous solution
In small beaker, it is transferred to completely in 100mL volumetric flasks, 100mL is settled to deionized water, rocks uniform, will raw sample
It is diluted to 0.1% OPC microcapsules and the 0.1% OPC aqueous solution;It is standby.
2. load stirrer in reception tank, and fill reception liquid, by artificial skin be fixed on diffusion cell supply pool and
Between reception tank (bright to face supply pool, dark face towards reception tank), skin is set to be immersed in solution below.
3. 3mL is pipetted containing 0.1% OPC microcapsules in supply pool with 1mL liquid-transfering guns, same method pipettes 3mL
Containing the 0.1% OPC aqueous solution in supply pool, as supply liquid.
4. set recirculated water temperature be 37 DEG C, rotating speed is 400r/min, respectively 1h, 2h, 4h, 6h, 8h, 10h, 12h,
1mL reception liquids are extracted with 1mL medical aseptics syringe when 24h, 36h, while supplementing the fresh reception liquid of same volume.Sample passes through
After 0.22 μm of filtering membrane filtration, the concentration of filtrate procyanidins is surveyed with efficient liquid phase.
Experimental result:
Wherein, Cn:Reception liquid drug concentration, μ g/mL when n-th is sampled;
V:Reception liquid volume in receiving chamber, 17mL;
Ci:Reception liquid drug concentration, μ g/mL when i & lt is sampled;
1.0:Each sample volume, mL;
S:Effective infiltrating area, 1cm2;
Q:Permeability, μ g/cm2。
Embodiment 1:
In terms of 1000g formula materials, OPC 1g, lipophilic emulsifier 10g, shitosan 10g, glacial acetic acid 10g, water are taken
10g, glutaraldehyde 0.05g, liquid fat 958.95g.
Described lipophilic emulsifier is ceteareth -6;
Described liquid fat is caprylic capric glyceryl ester;
The step of preparation method, is as follows:
1) acetum is made by glacial acetic acid is soluble in water;
2) add chitosan into step 1) in prepared acetum, 30 DEG C are heated to being completely dissolved, and standing is removed
Chitosan-acetic acid solution is obtained after removing bubble;
3) OPC is added to step 2) in prepared solution, 25 DEG C stir after solution a;
4) lipophilic emulsifier is added in liquid fat, solution b is obtained after being stirred in 25 DEG C of waters bath with thermostatic control;
5) in 25 DEG C of heated at constant temperature solution b, the agitating solution b under the stir speed (S.S.) of 200rpm, while solution a is slowly dripped
Enter in solution b, emulsify 1.5 hours;
6) in step 5) glutaraldehyde is added dropwise in the prepared system for completing, continuation is stirred under the stir speed (S.S.) of 200rpm
Mix 1.5 hours;
7) by step 6) prepared by reactant be fully transferred in centrifuge tube, under the rotating speed of 10000rpm centrifugation point
From obtaining sediment.
8) by step 7) in gained sediment respectively with absolute ethanol washing once, petroleum ether three times.Washed product
Volatilized naturally after being disperseed with proper amount of acetone, obtain OPC microcapsules.
The case of comparative examples of embodiment 1:
Configure the 1% OPC aqueous solution.
OPC microcapsules to the gained of above-described embodiment 1 and being spent containing 1% original obtained by the comparative examples of embodiment 1
Blue or green element aqueous solution permeability data is determined, and as a result be see the table below:
Embodiment 2:
In terms of 1000g formula materials, OPC 50g, lipophilic emulsifier 300g, shitosan 100g, glacial acetic acid are taken
100g, water 300g, glutaraldehyde 1g, liquid fat 149g.
Described lipophilic emulsifier is ceteareth -25;
Described liquid fat is isopropyl myristate;
The step of preparation method, is as follows:
1) acetum is made by glacial acetic acid is soluble in water;
2) add chitosan into step 1) in prepared acetum, 60 DEG C are heated to being completely dissolved, and standing is removed
Chitosan-acetic acid solution is obtained after removing bubble;
3) OPC is added to step 2) in prepared solution, 50 DEG C stir after solution a;
4) lipophilic emulsifier is added in liquid fat, solution b is obtained after being stirred in 60 DEG C of waters bath with thermostatic control;
5) in 60 DEG C of heated at constant temperature solution b, the agitating solution b under the stir speed (S.S.) of 1000rpm, while solution a is slow
It is added dropwise in solution b, emulsifies 4 hours;
6) in step 5) glutaraldehyde of 1g is added dropwise in the prepared system for completing, continue the stirring speed in 1000rpm
Stirred 4 hours under rate;
7) by step 6) prepared by reactant be fully transferred in centrifuge tube, under the rotating speed of 40000rpm centrifugation point
From obtaining sediment.
8) by step 7) in gained sediment respectively with absolute ethanol washing once, petroleum ether three times.Washed product
Volatilized naturally after being disperseed with proper amount of acetone, obtain OPC microcapsules.
Embodiment 3:
In terms of 1000g formula materials, OPC 25g, lipophilic emulsifier 150g, shitosan 50g, glacial acetic acid 50g are taken,
Water 150g, glutaraldehyde 0.5g, liquid fat 574.5g.
Described lipophilic emulsifier is the isostearate of polyglycereol -2 three;
Described liquid fat is isopropyl palmitate;
The step of preparation method, is as follows:
1) acetum is made by glacial acetic acid is soluble in water;
2) add chitosan into step 1) in prepared acetum, 45 DEG C are heated to being completely dissolved, and standing is removed
Chitosan-acetic acid solution is obtained after removing bubble;
3) OPC is added to step 2) in prepared solution, 40 DEG C stir after solution a;
4) lipophilic emulsifier is added in liquid fat, solution b is obtained after being stirred in 40 DEG C of waters bath with thermostatic control;
5) in 40 DEG C of heated at constant temperature solution b, the agitating solution b under the stir speed (S.S.) of 500rpm, while solution a is slowly dripped
Enter in solution b, emulsify 2.5 hours;
6) in step 5) glutaraldehyde is added dropwise in the prepared system for completing, continuation is stirred under the stir speed (S.S.) of 500rpm
Mix 2.5 hours;
7) by step 6) prepared by reactant be fully transferred in centrifuge tube, under the rotating speed of 25000rpm centrifugation point
From obtaining sediment.
8) by step 7) in gained sediment respectively with absolute ethanol washing once, petroleum ether three times.Washed product
Volatilized naturally after being disperseed with proper amount of acetone, obtain OPC microcapsules.
Above said content is only the basic explanation under present inventive concept, and according to appointing that technical scheme is made
What equivalent transformation, all should belong to protection scope of the present invention.
Claims (3)
1. a kind of OPC microcapsules, it is characterised in that be prepared from by the raw material of following mass percent:
OPC 0.1~5%,
Lipophilic emulsifier 1~30%,
Shitosan 1~10%,
Glacial acetic acid 1~10%,
Water 1~30%,
Glutaraldehyde 0.005~0.1%,
Liquid fat surplus;
Described lipophilic emulsifier is ceteareth -6, ceteareth -25, cetyl polyethylene glycol/poly-
The dimethyl siloxane of propane diols -10/1, the polyricinoleate of polyglycereol -3, the isostearate of polyglycereol -2, polyglycereol -2 pairs are different
Stearate, the isostearate of polyglycereol -2 three, the pentaerythritol tetraisostearate of polyglycereol -2, sorbitan monooleate, Sorbitan
Alcohol stearate, sorbitan sesquioleate, sorbitan trioleate, polyoxyethylene(2)Oleyl alcohol ether, polyoxyethylene
(10)One or more mixtures for being constituted in oleyl alcohol ether;
Described liquid fat is different caprylic capric glyceryl ester, isopropyl myristate, myristyl myristate, palmitic acid
Propyl ester, isobutyl palmitate, ethylhexyl palmitate, isoamyl laurate, isostearic acid, isooctadecanol, pentaerythrite four are different
Stearic acid, isostearic acid glyceryl ester, isopropyl isostearate, the pungent decylate of trimethylolpropane tris, neopentyl glycol two are different hard
One kind in resin acid, cetearyl stearate, n-nonanoic acid cetearyl alcohol ester, PEG-7 cocounut oil acid glyceride, three isooctyl acid glyceride
Or two or more constituted mixtures.
2. the preparation method of a kind of OPC microcapsules described in claim 1, it is characterised in that comprise the following steps:
1)OPC, lipophilic emulsifier, shitosan, glacial acetic acid, water, glutaraldehyde, fluid oil are weighed according to mass percent
Fat;
2)Acetum is made by glacial acetic acid is soluble in water;
3)Add chitosan into step 2) in prepared acetum, 30~60 DEG C are heated to being completely dissolved, and standing is removed
Chitosan-acetic acid solution is obtained after removing bubble;
4)OPC is added to step 3) in prepared solution, 25~50 DEG C stir after the first solution;
5)Lipophilic emulsifier is added in liquid fat, the second solution is obtained after being stirred in 25~60 DEG C of waters bath with thermostatic control;
6)In 25~60 DEG C of solution of heated at constant temperature second, the second solution is stirred under the stir speed (S.S.) of 150rpm~1000rpm, together
When the first solution is slowly dropped into in the second solution, emulsify 0.5~4 hour;
7)In step 6) it is added dropwise in glutaraldehyde in the prepared system for completing, continue the stirring in 150rpm~1000rpm
Stirred 0.5~4 hour under speed;
8)By step 7) prepared by reactant be fully transferred in centrifuge tube, under the rotating speed of 10000~40000rpm be centrifuged
Separate, obtain sediment;
9)By step 8) in gained sediment respectively use absolute ethyl alcohol and petroleum ether, washed product acetone dispersion after wave naturally
It is dry, obtain OPC microcapsules.
3. application of the OPC microcapsules described in claim 1 in food, health food, medicine or cosmetics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710035742.1A CN106852726A (en) | 2017-01-17 | 2017-01-17 | A kind of OPC microcapsules and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710035742.1A CN106852726A (en) | 2017-01-17 | 2017-01-17 | A kind of OPC microcapsules and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106852726A true CN106852726A (en) | 2017-06-16 |
Family
ID=59126797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710035742.1A Pending CN106852726A (en) | 2017-01-17 | 2017-01-17 | A kind of OPC microcapsules and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106852726A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108402464A (en) * | 2018-04-04 | 2018-08-17 | 江南大学 | One kind is rich in wild cherry certain kind of berries anthocyanidin microcapsules and preparation method thereof |
CN108403574A (en) * | 2018-06-08 | 2018-08-17 | 桃源县兴隆米业科技开发有限公司 | A kind of preparation method based on purple rice extracting solution whitening moisturizing face masque |
CN109259234A (en) * | 2018-11-19 | 2019-01-25 | 福建农林大学 | It is a kind of using resistant starch as the procyanidine microcapsules and preparation method of wall material |
CN109999767A (en) * | 2019-04-17 | 2019-07-12 | 江苏师范大学 | A kind of method of glutaraldehyde modification of chitosan resin adsorption separation purple sweet potato anthocyanin |
CN110664705A (en) * | 2019-10-30 | 2020-01-10 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of sweet potato anthocyanin eye shadow |
CN111840115A (en) * | 2020-08-17 | 2020-10-30 | 蓝科恒业医疗科技(长春)有限公司 | Procyanidine oligomer-based facial hormone-dependent dermatitis treatment liquid and preparation method thereof |
CN114698844A (en) * | 2022-04-11 | 2022-07-05 | 湖北工业大学 | Application of chitosan procyanidin composition in inhibiting formation of gastrointestinal pentostatin |
CN114794479A (en) * | 2022-05-20 | 2022-07-29 | 中国计量大学 | Preparation method of procyanidine-chitosan microgel |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383819A (en) * | 2002-05-17 | 2002-12-11 | 天津市园艺工程研究所 | Protocyanidin slow release capsule |
-
2017
- 2017-01-17 CN CN201710035742.1A patent/CN106852726A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383819A (en) * | 2002-05-17 | 2002-12-11 | 天津市园艺工程研究所 | Protocyanidin slow release capsule |
Non-Patent Citations (2)
Title |
---|
柴少虎: "壳聚糖微球的制备及其对茶多酚EGCG的微胶囊载体作用", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
汪多仁: "《有机食品表面活性剂》", 30 April 2009, 科学技术文献出版社 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108402464A (en) * | 2018-04-04 | 2018-08-17 | 江南大学 | One kind is rich in wild cherry certain kind of berries anthocyanidin microcapsules and preparation method thereof |
CN108403574A (en) * | 2018-06-08 | 2018-08-17 | 桃源县兴隆米业科技开发有限公司 | A kind of preparation method based on purple rice extracting solution whitening moisturizing face masque |
CN109259234A (en) * | 2018-11-19 | 2019-01-25 | 福建农林大学 | It is a kind of using resistant starch as the procyanidine microcapsules and preparation method of wall material |
CN109999767A (en) * | 2019-04-17 | 2019-07-12 | 江苏师范大学 | A kind of method of glutaraldehyde modification of chitosan resin adsorption separation purple sweet potato anthocyanin |
CN110664705A (en) * | 2019-10-30 | 2020-01-10 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of sweet potato anthocyanin eye shadow |
CN111840115A (en) * | 2020-08-17 | 2020-10-30 | 蓝科恒业医疗科技(长春)有限公司 | Procyanidine oligomer-based facial hormone-dependent dermatitis treatment liquid and preparation method thereof |
CN114698844A (en) * | 2022-04-11 | 2022-07-05 | 湖北工业大学 | Application of chitosan procyanidin composition in inhibiting formation of gastrointestinal pentostatin |
CN114794479A (en) * | 2022-05-20 | 2022-07-29 | 中国计量大学 | Preparation method of procyanidine-chitosan microgel |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106852726A (en) | A kind of OPC microcapsules and preparation method thereof | |
CN106309147B (en) | A kind of cosmetic composition and preparation method with high security | |
JP5563723B2 (en) | W / O / W emulsion having stability over time and method for producing the same | |
CN106580728A (en) | Vitamin C microcapsule and preparation method thereof | |
JP2003514008A (en) | Microencapsulation method | |
CN1323579A (en) | Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same | |
CN106619148A (en) | Water-soluble glabridin microcapsule and preparation method thereof | |
CN102822413A (en) | Process of treatment of fibers and/or textile materials | |
CN105030561B (en) | Contain ursin and ascorbic fibroin albumen microballoon and preparation method and application | |
CN102274192B (en) | Carboxymethyl chitosan medicament-carrying microspheres and preparation method thereof | |
CN104856963A (en) | Astaxanthin-sodium alginate sustained release microspheres as well as preparation method and application thereof | |
CN105248444B (en) | A kind of athomin microcapsule controlled-release agent using silica as carrier and preparation method thereof | |
CN111420069A (en) | Gla-ZIFs inclusion compound and preparation method and application thereof | |
CN108210346B (en) | Composite wall material microcapsule loaded with salicylic acid and preparation method thereof | |
CN101618016B (en) | Method for preparing W/O/W type compound emulsion embedding chlorogenic acid, product and application of W/O/W type compound emulsion | |
CN107595655A (en) | A kind of salicylic drug-loading system and its preparation method and application | |
CN105213225B (en) | A kind of Anti-radiation facial cream containing blumea oil | |
CN101524317B (en) | Skin-care cosmetic containing nonane diacid for dispelling freckles | |
CN101658495B (en) | Hydrobromic acid lappaconitine solid lipid nano particle and preparation method thereof | |
WO2019045397A2 (en) | Cosmetic composition containing high content of oil component and sheet mask using same | |
CN103990136B (en) | Transdermal drug delivery system, preparation method and application thereof | |
CN106821791A (en) | A kind of niacinamide microcapsules and preparation method thereof | |
CN106667793A (en) | D-panthenol microcapsules and preparation method thereof | |
CN102697663B (en) | Composite sun-screening agent nano-structure lipid carrier and preparation method thereof | |
CN102028633A (en) | Egcg/polyester resin complex, process for preparing the same and cosmetic composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170616 |